The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients.


Journal

Transplantation direct
ISSN: 2373-8731
Titre abrégé: Transplant Direct
Pays: United States
ID NLM: 101651609

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 17 07 2019
accepted: 04 08 2019
entrez: 15 11 2019
pubmed: 15 11 2019
medline: 15 11 2019
Statut: epublish

Résumé

It is unclear if immunosuppression increases the likelihood of malignant transformation of monoclonal gammopathy of undetermined significance (MGUS) and whether adverse renal outcomes in kidney transplant recipients with MGUS are more frequent. We performed a retrospective cohort study of kidney transplant recipients at the Centre Hospitalier de l'Université de Montréal between 2000 and 2016. Among 755 study participants, 13 (1.7%) were found to have MGUS before transplant. Two evolved to smoldering multiple myeloma and 2 presented paraprotein-induced allograft injury from light chain deposition disease. Forty-six patients developed posttransplant MGUS (2.5% 5-y cumulative incidence) of which 1 progressed to multiple myeloma and 1 experienced kidney allograft loss from light chain deposition disease. None of the patients with a malignant transformation or paraprotein-induced renal disease after transplantation had had a systematic workup before transplantation to exclude hematologic malignancies and paraprotein-related kidney injury. Nine posttransplant MGUS (21%) were transient. Multivariable analysis revealed that age at transplant (hazard ratio 1.05 per 1-y increase, 95% confidence intervals, 1.02-1.08) and prior cytomegalovirus infection (hazard ratio 2.22, 95% confidence intervals, 1.07-4.58) were associated with the development of MGUS after transplantation. Of 7 posttransplant lymphoproliferative disorders, none were preceded by MGUS. Our results suggest that the identification of MGUS in a transplant candidate should lead to further investigations to exclude a plasma cell neoplasm and monoclonal gammopathy of renal significance before transplantation. MGUS arising after transplantation appears to carry a favorable evolution.

Identifiants

pubmed: 31723584
doi: 10.1097/TXD.0000000000000937
pmc: PMC6791600
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e489

Informations de copyright

Copyright © 2019 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.

Références

Am J Transplant. 2017 Jan;17(1):103-114
pubmed: 27575845
N Engl J Med. 2007 Jun 21;356(25):2582-90
pubmed: 17582068
N Engl J Med. 2006 Mar 30;354(13):1362-9
pubmed: 16571879
Am J Kidney Dis. 2004 Jan;43(1):147-53
pubmed: 14712438
Transplantation. 2004 May 27;77(10):1551-4
pubmed: 15239620
Transplantation. 2017 Nov;101(11):e337-e342
pubmed: 28731904
Lancet Oncol. 2014 Nov;15(12):e538-48
pubmed: 25439696
Clin Transplant. 2015 Sep;29(9):851-7
pubmed: 26194021
Blood. 2005 Aug 1;106(3):812-7
pubmed: 15855274
Transplant Proc. 2001 Feb-Mar;33(1-2):1583-4
pubmed: 11267429
Kidney Int. 2009 Feb;75(4):420-7
pubmed: 19037251
Transpl Int. 2015 Mar;28(3):375-9
pubmed: 25441103
N Engl J Med. 2018 Jan 18;378(3):241-249
pubmed: 29342381
Liver Transpl Surg. 1996 Sep;2(5):375-82
pubmed: 9346679
Clin J Am Soc Nephrol. 2012 Feb;7(2):231-9
pubmed: 22156754
Blood. 2018 Oct 4;132(14):1464-1465
pubmed: 30287466
Transplantation. 2011 Sep 15;92(5):570-4
pubmed: 21712755
Transplant Proc. 2015 Oct;47(8):2344-5
pubmed: 26518922
Blood. 2001 Sep 1;98(5):1332-8
pubmed: 11520779
Transpl Int. 1992;5 Suppl 1:S23-5
pubmed: 14621723
Mayo Clin Proc. 2010 Oct;85(10):933-42
pubmed: 20713974
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Clin J Am Soc Nephrol. 2011 Jan;6(1):122-32
pubmed: 20876681
N Engl J Med. 2002 Feb 21;346(8):564-9
pubmed: 11856795
Am J Nephrol. 2012;35(4):365-71
pubmed: 22473253
Nephrol Dial Transplant. 1996 Dec;11(12):2461-5
pubmed: 9017623
Transplant Proc. 1998 Aug;30(5):2079-82
pubmed: 9723398
Transpl Int. 2012 Jan;25(1):25-33
pubmed: 21999283
Blood. 2013 Nov 21;122(22):3583-90
pubmed: 24108460
Am J Transplant. 2009 Nov;9 Suppl 3:S1-155
pubmed: 19845597
Blood. 2012 Nov 22;120(22):4292-5
pubmed: 23047823
Am J Nephrol. 1994;14(3):187-91
pubmed: 7977478
Transplantation. 2011 Dec 27;92(12):e65-6; author reply e66
pubmed: 22158469

Auteurs

Marie-France Gagnon (MF)

Division of Hematology-Oncology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.

Héloïse Cardinal (H)

Division of Nephrology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.

Jean-Pierre Emond (JP)

Department of Biochemistry, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.

Mathieu Latour (M)

Department of Pathology and Cell Biology, Centre Hospitalier de l'Université de Montréal, QC, Canada.

Bernard Lemieux (B)

Division of Hematology-Oncology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.

Classifications MeSH